American Academy of Pediatrics Child and Adolescent Immunization Schedule for United States 2026
The American Academy of Pediatrics updated its child and adolescent immunization schedule, establishing updated timing for respiratory syncytial virus monoclonal antibodies, hepatitis B, rotavirus, and DTaP vaccines. The updated guidance, released on September 2, 2026, details recommended intervals and catch-up schedules for young patients across the United States.
Vaccine Schedule Adjustments for Pediatric Patients
The updated framework provides practitioners and families with a clear roadmap for childhood immunizations, detailing specific age brackets from birth through 18 years. Clinicians determine recommended vaccines by age using Table 1 of the guidance, while Table 3 outlines additional requirements based on underlying medical conditions or special health indicators. When a patient presents with an incomplete or unknown immunization history, the American Academy of Pediatrics directs providers to administer recommended doses at subsequent visits rather than restarting or adding doses to an existing series.
The guidance outlines specific reporting pathways for adverse events. For respiratory syncytial virus monoclonal antibody products such as nirsevimab and clesrovimab, providers must submit clinically significant adverse events to the MedWatch Adverse Event Report Program. If these products are co-administered with other immunizing agents, clinicians report adverse events through VAERS. Questions or comments regarding the immunization schedule can be submitted directly through the American Academy of Pediatrics feedback portal.
Interagency Endorsements Supporting the Updated Framework
The updated immunization schedule carries broad medical consensus. The American Academy of Family Physicians, American College of Nurse-Midwives, American College of Obstetricians and Gynecologists, American Medical Association, and American Pharmacists Association have all endorsed the guidance. Additional organizational backing comes from the Council of Medical Specialty Societies, the Infectious Diseases Society of America, the National Association of Pediatric Nurse Practitioners, the National Medical Association, the Pediatric Infectious Diseases Society, the Pediatric Pharmacy Association, and the Society for Adolescent Health and Medicine.
Medical Providers Use Guidance and Tools for Vaccinations
Medical providers following complex catch-up vaccination timelines rely on Table 2 of the guidance to establish recommended intervals between doses. The appendix details specific contraindications and precautions for each vaccine type. Pediatric clinics and family medicine practices utilize shared clinical decision-making tools provided by the American Academy of Pediatrics to discuss immunization options with parents and guardians.
For specialized guidance, practitioners review comprehensive notes covering vaccine types, frequencies, and intervals for special situations. The use of commercial trade names within the guidance serves strictly for identification purposes and does not constitute an endorsement by the American Academy of Pediatrics.